A low endothelial cell count can rule out EVO ICL, even when the prescription and other measurements appear suitable. FDA patient labeling says the lens should not be implanted when the minimum endothelial cell density for the patient's age is not met. An online count comparison cannot clear you for surgery.

The EVO ICL service explains the broader evaluation. This guide focuses on endothelial eligibility before implantation; the vault measurements guide addresses a different question about lens fit and monitoring.

Why does the cell count matter?

Endothelial cells line the inner cornea and help keep it clear by managing fluid. Their number normally declines with age, and eye surgery can cause additional loss. Too few functioning cells can lead to corneal swelling and reduced vision.

EVO ICL is placed inside the eye while the natural lens remains. The fact that it avoids reshaping the cornea does not remove the need to evaluate corneal health. Ask why the measured endothelial reserve is considered adequate for the proposed procedure and longer-term care.

Is there one safe cutoff for everyone?

Do not use a single number from a forum as a universal threshold. The device's patient labeling makes the minimum age-dependent. The surgeon needs to apply the labeling for the actual lens and evaluate the rest of the eye, including the chamber dimensions and drainage angle.

Request your measured density for each eye and an explanation of how it compares with the applicable criteria. Ask whether image quality or unexpected findings require confirmation. A second opinion should review the original measurements and diagnosis rather than simply look for someone willing to accept a lower count.

What if two clinics give different answers?

Bring the cell-count reports, instrument images if available, chamber measurements, and history of previous surgery or corneal disease. Ask the clinicians to explain whether the disagreement concerns measurement quality, interpretation, different device criteria, or another suitability finding.

Do not assume the more permissive recommendation is better. Before committing to an elective operation, you should understand the reason for each recommendation and the uncertainties that remain. A cornea consultation may help clarify an abnormal endothelial finding when appropriate.

What monitoring would be needed after implantation?

FDA information describes the importance of continuing eye examinations and endothelial monitoring with a phakic lens. Ask who performs those checks, how results are compared over time, and what change would trigger additional review.

Lens removal is another operation and cannot be assumed to reverse cell loss that has already occurred. Ask about this distinction when evaluating claims that ICL is removable. Also discuss how the monitoring plan would continue if you moved away from DFW or changed eye-care providers.

What alternatives should you compare before booking?

If ICL is unsuitable, ask which options are reasonable for your actual eye findings. Glasses or contact lenses may remain the best choice. LASIK, PRK, or lens replacement each requires a separate assessment; none becomes safe simply because ICL was declined.

A consultation should connect the recommendation to your measurements, goals, and expected follow-up. Request a clear eligibility explanation before discussing a procedure date, financing, or deposit. The useful decision is whether the benefit justifies the risk for your eyes.